Literature DB >> 12706468

L-type Ca(2+) channel blockers inhibit the development but not the expression of sensitization to morphine in mice.

Qi Zhang1, Jun-Xu Li, Ji-Wang Zheng, Rui-Ke Liu, Jian-Hui Liang.   

Abstract

The relationship between opioid actions and L-type Ca(2+) channel blockers has been well documented. However, there is no report relevant to L-type Ca(2+) channel blockers and morphine sensitization, which is suggested to be an analog of behaviors that are characteristic of drug addiction. We now studied systematically the effects of three L-type Ca(2+) channel blockers, nimodipine, nifedipine and verapamil, on morphine-induced locomotor activity, the development and the expression of sensitization to morphine. The results showed that both nimodipine and verapamil attenuated, while nifedipine had only a tendency to decrease morphine-induced locomotor activity. All three drugs inhibited the development of sensitization to morphine. However, none of them showed any effects on the expression of morphine sensitization. These results indicate that blocking L-type Ca(2+) channel attenuates the locomotor-stimulating effects of morphine and inhibits the development but not the expression of morphine sensitization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706468     DOI: 10.1016/s0014-2999(03)01567-x

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  5 in total

1.  The role of L-type calcium channels in the development and expression of behavioral sensitization to ethanol.

Authors:  Julie Broadbent
Journal:  Neurosci Lett       Date:  2013-08-28       Impact factor: 3.046

Review 2.  From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms.

Authors:  Zeeba D Kabir; Arlene Martínez-Rivera; Anjali M Rajadhyaksha
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

3.  Huperzine A inhibits immediate addictive behavior but not behavioral sensitization following repeated morphine administration in rats.

Authors:  Jinling Sun; Lin Tian; Ruisi Cui; Xinwang Li
Journal:  Exp Ther Med       Date:  2017-02-02       Impact factor: 2.447

4.  Cyclic AMP-dependent protein kinase A regulates the alternative splicing of CaMKIIδ.

Authors:  Qingqing Gu; Nana Jin; Hongzhuan Sheng; Xiaomin Yin; Jianhua Zhu
Journal:  PLoS One       Date:  2011-11-22       Impact factor: 3.240

5.  Bulleyaconitine A Inhibits Morphine-Induced Withdrawal Symptoms, Conditioned Place Preference, and Locomotor Sensitization Via Microglial Dynorphin A Expression.

Authors:  Meng-Jing Zhao; Mi-Ya Wang; Le Ma; Khalil Ali Ahmad; Yong-Xiang Wang
Journal:  Front Pharmacol       Date:  2021-02-26       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.